Magnetic EV Glycan Analysis Using Microfluidic Nanoparticle Separation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current analytical technologies for profiling extracellular vesicle (EV) glycans are limited by sensitivity, requiring extensive sample processing and are not suitable for detecting rare targets in complex biological specimens, due to weak interactions between lectins and glycans.
Innovation Solution
A microfluidic device utilizing magnetic nanoparticles functionalized to bind with EVs and aggregate with glycans, combined with a magnetic sensor for real-time measurement, enabling rapid and multiplexed analysis of EV glycans in native clinical biofluids.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If mass spectrometry is used for carbohydrate structural analysis, then comprehensive measurements are enabled, but extensive processing and large sample amount are required
Solution Approach 1:
The patent extracts and isolates EV glycans from complex biological samples using magnetic nanoparticles that specifically bind to glycan structures. This extraction process simplifies the overall analysis by pre-concentrating the target analytes before mass spectrometry, thereby reducing the need for extensive processing steps and large sample amounts while maintaining comprehensive structural analysis capability
Solution Approach 2:
Magnetic nanoparticles serve as an intermediary between the complex biological sample and the mass spectrometry instrument. These nanoparticles functionalized with glycan-binding proteins facilitate selective capture and concentration of EV glycans, acting as a bridge that simplifies the interface between sample preparation and analytical measurement, thus reducing processing complexity
2Ease of operation
If lectin microarray is used for EV glycan analysis, then simplified alternative is provided, but limited sensitivity is achieved
Solution Approach 1:
The patent changes the fundamental parameter of detection by transitioning from optical detection (fluorescence) in lectin microarrays to magnetic detection using magnetic nanoparticles and magnetometers. This parameter change enables significantly enhanced sensitivity for detecting rare EV glycans while maintaining the simplified operational approach, as the magnetic signal provides superior detection capability compared to fluorescent signals
Solution Approach 2:
The patent employs composite magnetic nanoparticles that combine magnetic core materials with glycan-binding protein coatings. This composite structure integrates the detection capability of magnetic particles with the specific binding affinity of lectins, achieving both simplified operation and enhanced sensitivity by merging the advantages of both approaches into a single functional platform
3Ease of operation
If solid-phase immobilization of lectins is used, then assay is simplified, but weak interactions limit performance for rare targets
Solution Approach 1:
The patent replaces the solid-phase immobilization mechanical system with a solution-phase magnetic nanoparticle system. Instead of fixing lectins to a solid surface where interactions are limited by surface area and diffusion, the magnetic nanoparticles remain in solution and can dynamically bind to EV glycans through stronger, more reliable interactions. This substitution maintains assay simplification while dramatically improving interaction strength and detection reliability for rare targets
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device allows for rapid, wash-free, and multiplexed analysis of EV glycans, revealing glycan signatures and differentiating patient prognosis through direct EV glycan analysis, with high sensitivity and minimal sample processing.
Implementation Method 1
magnetic nanoparticles functionalized to bind with extracellular vesicles and aggregate to vesicle glycans in the fluid sample
Implementation Method 2
a magnetic sensor configured to measure magnetic properties of the fluid sample after it has passed through the magnetic separation portion
Data Source
AI summary
Devices and methods for analysing extracellular vesicle glycans are described. According to an embodiment, a microfluidic device comprises an inlet portion configured to receive a fluid sample; a mixing portion fluidically coupled to the inlet portion and configured to facilitate mixing between the fluid sample and magnetic nanoparticles functionalized to bind with extracellular vesicles and aggregate to vesicle glycans in the fluid sample; a magnetic separation portion fluidically coupled to the mixing portion and configured to separate clusters of magnetic nanoparticles from the fluid sample; and a magnetic sensor configured to measure magnetic properties of the fluid sample after it has passed through the magnetic separation portion. The magnetic nanoparticles may configured to aggregate in the presence of respective lectins when bound with extracellular vesicles carrying target glycans. In a specific embodiment, the magnetic particles comprise a magnetic polycore coated with polydopamine.